Annual report
3645.TEDINET S100P43U
Period2021-06-01 → 2022-05-31
Filed2022-08-31
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.7bn | 2021-06-01 → 2022-05-31 | Cons. | Net sales |
| Revenue | ¥2.9bn | 2020-06-01 → 2021-05-31 | Cons. | Net sales |
| Revenue | ¥2.6bn | 2019-06-01 → 2020-05-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.0bn | 2018-06-01 → 2019-05-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.5bn | 2017-06-01 → 2018-05-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥450m | 2021-06-01 → 2022-05-31 | Cons. | Operating income |
| Operating income | ¥331m | 2020-06-01 → 2021-05-31 | Cons. | Operating income |
| Ordinary income | ¥454m | 2021-06-01 → 2022-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥336m | 2020-06-01 → 2021-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥104m | 2019-06-01 → 2020-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥183m | 2018-06-01 → 2019-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥155m | 2017-06-01 → 2018-05-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥539m | 2021-06-01 → 2022-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥254m | 2020-06-01 → 2021-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥385m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥130m | 2020-06-01 → 2021-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥79m | 2019-06-01 → 2020-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥102m | 2018-06-01 → 2019-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥88m | 2017-06-01 → 2018-05-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥401m | 2021-06-01 → 2022-05-31 | Cons. | Profit loss |
| Net income | ¥138m | 2020-06-01 → 2021-05-31 | Cons. | Profit loss |
| Total assets | ¥3.2bn | at 2022-05-31 | Cons. | Assets |
| Total assets | ¥2.1bn | at 2021-05-31 | Cons. | Assets |
| Total assets | ¥1.7bn | at 2020-05-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥2.1bn | at 2019-05-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.9bn | at 2018-05-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.4bn | at 2022-05-31 | Cons. | Liabilities |
| Total liabilities | ¥847m | at 2021-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.7bn | at 2022-05-31 | Cons. | Net assets |
| Net assets / equity | ¥1.3bn | at 2021-05-31 | Cons. | Net assets |
| Net assets / equity | ¥1.0bn | at 2020-05-31d | Cons. | Net assets |
| Net assets / equity | ¥1.6bn | at 2019-05-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.6bn | at 2018-05-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2022-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥869m | at 2021-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.1bn | at 2022-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥869m | at 2021-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥596m | at 2020-05-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.0bn | at 2019-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.2bn | at 2018-05-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥343m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥392m | 2020-06-01 → 2021-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥78m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥22m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥116m | 2017-06-01 → 2018-05-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥355m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥88m | 2020-06-01 → 2021-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥15m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥145m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥43m | 2017-06-01 → 2018-05-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥282m | 2021-06-01 → 2022-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥34m | 2020-06-01 → 2021-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥497m | 2019-06-01 → 2020-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥21m | 2018-06-01 → 2019-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥50m | 2017-06-01 → 2018-05-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥43.98 | 2021-06-01 → 2022-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.36 | 2020-06-01 → 2021-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.26 | 2019-06-01 → 2020-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥9.49 | 2018-06-01 → 2019-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.18 | 2017-06-01 → 2018-05-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥193.73 | at 2022-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥144.23 | at 2021-05-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥123.32 | at 2020-05-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥151.83 | at 2019-05-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥143.51 | at 2018-05-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 54.1% | at 2022-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.0% | at 2021-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.4% | at 2020-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.7% | at 2019-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.0% | at 2018-05-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 26.1% | 2021-06-01 → 2022-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.6% | 2020-06-01 → 2021-05-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2019-06-01 → 2020-05-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.4% | 2018-06-01 → 2019-05-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.8% | 2017-06-01 → 2018-05-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 163 | at 2022-05-31 | Cons. | Number of employees |
| Employees | 113 | at 2021-05-31 | Cons. | Number of employees |
| Employees | 110 | at 2020-05-31d | Cons. | Number of employees |
| Employees | 102 | at 2019-05-31d | Cons. | Number of employees |
| Employees | 98 | at 2018-05-31d | Cons. | Number of employees |
| Revenue | ¥1.6bn | 2021-06-01 → 2022-05-31 | Standalone | Net sales |
| Revenue | ¥1.4bn | 2020-06-01 → 2021-05-31 | Standalone | Net sales |
| Revenue | ¥1.2bn | 2019-06-01 → 2020-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.3bn | 2018-06-01 → 2019-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.4bn | 2017-06-01 → 2018-05-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥365m | 2021-06-01 → 2022-05-31 | Standalone | Operating income |
| Operating income | ¥318m | 2020-06-01 → 2021-05-31 | Standalone | Operating income |
| Ordinary income | ¥352m | 2021-06-01 → 2022-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥322m | 2020-06-01 → 2021-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥97m | 2019-06-01 → 2020-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥237m | 2018-06-01 → 2019-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥194m | 2017-06-01 → 2018-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥351m | 2021-06-01 → 2022-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥240m | 2020-06-01 → 2021-05-31 | Standalone | Income before income taxes |
| Net income | ¥248m | 2021-06-01 → 2022-05-31 | Standalone | Profit loss |
| Net income | ¥137m | 2020-06-01 → 2021-05-31 | Standalone | Profit loss |
| Net income | ¥70m | 2019-06-01 → 2020-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥49m | 2018-06-01 → 2019-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥137m | 2017-06-01 → 2018-05-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.5bn | at 2022-05-31 | Standalone | Assets |
| Total assets | ¥1.8bn | at 2021-05-31 | Standalone | Assets |
| Total assets | ¥1.5bn | at 2020-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.9bn | at 2019-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.0bn | at 2018-05-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥929m | at 2022-05-31 | Standalone | Liabilities |
| Total liabilities | ¥551m | at 2021-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.6bn | at 2022-05-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2021-05-31 | Standalone | Net assets |
| Net assets / equity | ¥1.0bn | at 2020-05-31d | Standalone | Net assets |
| Net assets / equity | ¥1.7bn | at 2019-05-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.6bn | at 2018-05-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥798m | at 2022-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥675m | at 2021-05-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥28.4 | 2021-06-01 → 2022-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥16.23 | 2020-06-01 → 2021-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.2 | 2019-06-01 → 2020-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.56 | 2018-06-01 → 2019-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.73 | 2017-06-01 → 2018-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥4 | 2021-06-01 → 2022-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥4 | 2020-06-01 → 2021-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥1.5 | 2019-06-01 → 2020-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥2 | 2018-06-01 → 2019-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥2 | 2017-06-01 → 2018-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥181.56 | at 2022-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥148.43 | at 2021-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥127.15 | at 2020-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥155.37 | at 2019-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥152 | at 2018-05-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 63.3% | at 2022-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.9% | at 2021-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.8% | at 2020-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.4% | at 2019-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.6% | at 2018-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 17.3% | 2021-06-01 → 2022-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.9% | 2020-06-01 → 2021-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.2% | 2019-06-01 → 2020-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.0% | 2018-06-01 → 2019-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.7% | 2017-06-01 → 2018-05-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 10,773,000 | at 2022-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,773,000 | at 2021-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,773,000 | at 2020-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,773,000 | at 2019-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,773,000 | at 2018-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 98 | at 2022-05-31 | Standalone | Number of employees |
| Employees | 89 | at 2021-05-31 | Standalone | Number of employees |
| Employees | 93 | at 2020-05-31d | Standalone | Number of employees |
| Employees | 79 | at 2019-05-31d | Standalone | Number of employees |
| Employees | 83 | at 2018-05-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 77
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-06-01 → 2022-05-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-06-01 → 2022-05-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-06-01 → 2022-05-31 | ¥4m |
| Mediaplatformreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥2m |
| Mediaplatformreportable segment | employees | at 2022-05-31 | 24 pure |
| Mediaplatformreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥994m |
| Mediaplatformreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥994m |
| Mediaplatformreportable segment | segment assets | at 2022-05-31 | ¥72m |
| Mediaplatformreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥616m |
| Medical B To Breportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥441,000 |
| Medical B To Breportable segment | employees | at 2022-05-31 | 8 pure |
| Medical B To Breportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥169m |
| Medical B To Breportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥169m |
| Medical B To Breportable segment | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥17,000 |
| Medical B To Breportable segment | segment assets | at 2022-05-31 | ¥19m |
| Medical B To Breportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥58m |
| Medical Institution Management Supportreportable segment | capex | 2021-06-01 → 2022-05-31 | ¥2m |
| Medical Institution Management Supportreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥10m |
| Medical Institution Management Supportreportable segment | employees | at 2022-05-31 | 108 pure |
| Medical Institution Management Supportreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥2.6bn |
| Medical Institution Management Supportreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥2.6bn |
| Medical Institution Management Supportreportable segment | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥888,000 |
| Medical Institution Management Supportreportable segment | segment assets | at 2022-05-31 | ¥2.3bn |
| Medical Institution Management Supportreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥208m |
| —segment total | capex | 2021-06-01 → 2022-05-31 | ¥2m |
| —segment total | depreciation | 2021-06-01 → 2022-05-31 | ¥12m |
| —segment total | revenue | 2021-06-01 → 2022-05-31 | ¥3.7bn |
| —segment total | revenue external | 2021-06-01 → 2022-05-31 | ¥3.7bn |
| —segment total | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥906,000 |
| —segment total | segment assets | at 2022-05-31 | ¥2.4bn |
| —segment total | segment profit | 2021-06-01 → 2022-05-31 | ¥882m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-06-01 → 2022-05-31 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-06-01 → 2022-05-31 | ¥12m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-06-01 → 2022-05-31 | ¥3.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-06-01 → 2022-05-31 | ¥3.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-06-01 → 2022-05-31 | ¥906,000 |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-05-31 | ¥2.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-06-01 → 2022-05-31 | ¥886m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2020-06-01 → 2021-05-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2020-06-01 → 2021-05-31 | ¥4m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2020-06-01 → 2021-05-31 | ¥4m |
| Mediaplatformreportable segment | capex | 2020-06-01 → 2021-05-31 | ¥1m |
| Mediaplatformreportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥1m |
| Mediaplatformreportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥891m |
| Mediaplatformreportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥891m |
| Mediaplatformreportable segment | segment assets | at 2021-05-31 | ¥127m |
| Mediaplatformreportable segment | segment profit | 2020-06-01 → 2021-05-31 | ¥590m |
| Medical B To Breportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥360,000 |
| Medical B To Breportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥134m |
| Medical B To Breportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥134m |
| Medical B To Breportable segment | revenue intersegment | 2020-06-01 → 2021-05-31 | ¥413,000 |
| Medical B To Breportable segment | segment assets | at 2021-05-31 | ¥18m |
| Medical B To Breportable segment | segment profit | 2020-06-01 → 2021-05-31 | ¥59m |
| Medical Institution Management Supportreportable segment | capex | 2020-06-01 → 2021-05-31 | ¥4m |
| Medical Institution Management Supportreportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥8m |
| Medical Institution Management Supportreportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥1.9bn |
| Medical Institution Management Supportreportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥1.9bn |
| Medical Institution Management Supportreportable segment | revenue intersegment | 2020-06-01 → 2021-05-31 | ¥998,000 |
| Medical Institution Management Supportreportable segment | segment assets | at 2021-05-31 | ¥946m |
| Medical Institution Management Supportreportable segment | segment profit | 2020-06-01 → 2021-05-31 | ¥83m |
| —segment total | capex | 2020-06-01 → 2021-05-31 | ¥6m |
| —segment total | depreciation | 2020-06-01 → 2021-05-31 | ¥9m |
| —segment total | revenue | 2020-06-01 → 2021-05-31 | ¥2.9bn |
| —segment total | revenue external | 2020-06-01 → 2021-05-31 | ¥2.9bn |
| —segment total | revenue intersegment | 2020-06-01 → 2021-05-31 | ¥1m |
| —segment total | segment assets | at 2021-05-31 | ¥1.1bn |
| —segment total | segment profit | 2020-06-01 → 2021-05-31 | ¥731m |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-06-01 → 2021-05-31 | ¥6m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-06-01 → 2021-05-31 | ¥9m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-06-01 → 2021-05-31 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-06-01 → 2021-05-31 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-06-01 → 2021-05-31 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-05-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-06-01 → 2021-05-31 | ¥735m |
| Mediaplatformreportable segment | employees | at 2022-05-31 | 24 pure |
| Medical B To Breportable segment | employees | at 2022-05-31 | 8 pure |
| Medical Institution Management Supportreportable segment | employees | at 2022-05-31 | 43 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,367
| Item | Context | Value | Unit |
|---|---|---|---|
| Net assets | CurrentYearInstant_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember | 1676000 | JPY |
| Net assets | CurrentYearInstant_NonConsolidatedMember | 1600629000 | JPY |
| Directors compensations sga | Prior1YearDuration_NonConsolidatedMember | 101446000 | JPY |
| Directors compensations sga | CurrentYearDuration_NonConsolidatedMember | 117694000 | JPY |
| Salaries and allowances sga | Prior1YearDuration_NonConsolidatedMember | 194584000 | JPY |
| Salaries and allowances sga | CurrentYearDuration_NonConsolidatedMember | 219615000 | JPY |
| Commission fee sga | Prior1YearDuration_NonConsolidatedMember | 70489000 | JPY |
| Commission fee sga | CurrentYearDuration_NonConsolidatedMember | 53793000 | JPY |
| Advertising expenses sga | Prior1YearDuration_NonConsolidatedMember | 70521000 | JPY |
| Advertising expenses sga | CurrentYearDuration_NonConsolidatedMember | 105183000 | JPY |
| Depreciation sga | Prior1YearDuration_NonConsolidatedMember | 3325000 | JPY |
| Depreciation sga | CurrentYearDuration_NonConsolidatedMember | 4600000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YearDuration_NonConsolidatedMember | 1842000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYearDuration_NonConsolidatedMember | 10842000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)有価証券報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2022-08-31 | |
| Fiscal year cover page | FilingDateInstant | Original text (Japanese)第21期（自 2021年６月１日 至 2022年５月31日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社メディカルネット | |
| Company name in english cover page | FilingDateInstant | Medical Net, Inc. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役会長CEO 平川 大 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都渋谷区幡ヶ谷一丁目34番14号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | （03）5790－5261 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)管理本部ゼネラルマネージャー 三宅 大祐 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都渋谷区幡ヶ谷一丁目34番14号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | （03）5790－5261 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)管理本部ゼネラルマネージャー 三宅 大祐 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E24982 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 36450 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社メディカルネット | |
| Filer name in english | FilingDateInstant | Medical Net, Inc. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Current fiscal year start date | FilingDateInstant | 2021-06-01 | |
| Current period end date | FilingDateInstant | 2022-05-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2022-05-31 | |
| Previous fiscal year start date | FilingDateInstant | 2020-06-01 | |
| Comparative period end date | FilingDateInstant | 2021-05-31 | |
| Previous fiscal year end date | FilingDateInstant | 2021-05-31 | |
| Next fiscal year start date | FilingDateInstant | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |